AT-1015, a novel serotonin2A receptor antagonist, improves resaturation of exercised ischemic muscle in hypercholesterolemic rabbits
- 1 March 2004
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 39 (3) , 661-667
- https://doi.org/10.1016/j.jvs.2003.10.022
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The severity of muscle ischemia during intermittent claudicationJournal of Vascular Surgery, 2002
- Oxygen Saturation Measurement of Calf Muscle During Exercise in Intermittent ClaudicationEuropean Journal of Vascular and Endovascular Surgery, 2002
- Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: A combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivoJournal of Vascular Surgery, 2001
- Near-infrared spectroscopy grades the severity of intermittent claudication in diabetics more accurately than ankle pressure measurementBritish Journal of Surgery, 2000
- Hyperlipemic-very low density lipoprotein, intermediate density lipoprotein and low density lipoprotein act synergistically with serotonin on vascular smooth muscle cell proliferationAtherosclerosis, 2000
- Serotonin and vasoconstrictor synergismLife Sciences, 1998
- An objective assessment of intermittent claudication by near-infrared spectroscopyEuropean Journal of Vascular Surgery, 1994
- Local Effect of Serotonin Released during Coronary AngioplastyNew England Journal of Medicine, 1994
- Quantitative detection of hemoglobin saturation in the liver with near-infrared spectroscopyHepatology, 1993
- Oversensitivity to serotonin of the collateralized vascular bed in rat hindquarters: mechanisms of increased vasoconstrictionEuropean Journal of Pharmacology, 1991